In a filing, Nektar Therapeutics revealed its President & CEO ROBIN HOWARD W unloaded Company’s shares for reported $13622.0 on Feb 20 ’24. In the deal valued at $0.68 per share,20,033 shares were sold. As a result of this transaction, ROBIN HOWARD W now holds 879,889 shares worth roughly $1.2 million.
Then, Zalevsky Jonathan sold 9,014 shares, generating $6,130 in total proceeds. Upon selling the shares at $0.68, the Chief R&D Officer now owns 265,025 shares.
Before that, Wilson Mark Andrew sold 7,606 shares. Nektar Therapeutics shares valued at $5,172 were divested by the Chief Legal Officer at a price of $0.68 per share. As a result of the transaction, Wilson Mark Andrew now holds 236,674 shares, worth roughly $0.32 million.
A number of analysts have revised their coverage, including TD Cowen’s analysts, who increased its forecast for the stock in early November from “a Market perform” to “an Outperform”. Jefferies also remained covering NKTR and has increased its forecast on May 10, 2023 with a “Hold” recommendation from previously “an Underperform” rating. Jefferies revised its rating on February 24, 2023. It rated NKTR as “an Underperform” which previously was an “a Hold”.
Price Performance Review of NKTR
On Monday, Nektar Therapeutics [NASDAQ:NKTR] saw its stock jump 9.68% to $1.36. Over the last five days, the stock has lost -13.38%. Nektar Therapeutics shares have risen nearly 140.71% since the year began. Nevertheless, the stocks have risen 57.92% over the past one year. While a 52-week high of $1.75 was reached on 04/11/24, a 52-week low of $0.41 was recorded on 01/18/24. SMA at 50 days reached $0.9695, while 200 days put it at $0.6704. A total of 1.97 million shares were traded, compared to the trading of 4.72 million shares in the previous session.
Levels Of Support And Resistance For NKTR Stock
The 24-hour chart illustrates a support level at 1.2967, which if violated will result in even more drops to 1.2333. On the upside, there is a resistance level at 1.4167. A further resistance level may holdings at 1.4733. The Relative Strength Index (RSI) on the 14-day chart is 58.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0583, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 48.75%. Stochastics %K at 46.89% indicates the stock is a holding.
